Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Nelson HD, Walker M, Zakher B, Mitchell J. Menopausal hormone therapy for the primary prevention of chronic conditions: systematic review to update the 2002 and 2005 U.S. Preventive Services Task Force Recommendations. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Synthesis No. 93. 2012 Authors' objectives To update evidence on the effectiveness of hormone therapy in reducing risks for chronic conditions, its adverse effects, and differences among population subgroups for the U.S. Preventive Services Task Force. Authors' conclusions Both hormone therapy regimens decreased fractures but increased stroke, thromboembolic events, gall bladder disease, and urinary incontinence. Estrogen plus progestin increased breast cancer and probable dementia, while estrogen alone decreased breast cancer. Indexing Status Subject indexing assigned by CRD MeSH Chronic Disease; Hormone Replacement Therapy; Humans; Menopause Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence AHRQ, Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA Email: AHRQTAP@ahrq.hhs.gov AccessionNumber 32013000762 Date abstract record published 25/10/2013 |